Greenbriar Growth Partners (GGP), a venture capital firm, has been an investor in Microsurgery Devices (MSD) for four-plus years, and has come into conflict with the company's founder. Should the Board's Nominating Committee re-nominate the VC investor, and should the board go along with the VC's push for a stock buy-back in the midst of the financial crisis, and so soon after the company's IPO?

This case examines fair value accounting under lAS 41 for a European-listed agricultural firm. Students identify the firm's core operations, distinguishing the IFRS treatment for three distinct assets: land; agricultural assets that reside on the land; and inventory harvested from the land. They also analyze key reporting decisions relating to the agricultural assets, which create frictions such that market value and book value do not converge despite the application of fair value for the majority of the firm's assets. The case also highlights how fair value accounting affects key valuation inputs such as earnings, and the implications for abnormal-earnings based valuation.